MGCD-265
货号：
20097-1mg 基本售价：
490.0 元 规格：
1 mg
产品信息
概述| 货号 | 20097-1mg |
| 描述 | MGCD-265 is an orally bioavailable, multi-targeted tyrosine kinase inhibitor, inhibiting MET, VGFR1-3, Tie, and Ron. Formulations containing MGCD-265, alone or in combination with other chemotherapeutic compounds, are being tested in animal models and clinical cancer trials, particularly for non-small cell lung cancer.1 |
| 别名 | Glesatinib; |
性能| 供应商 | Cayman |
| 应用文献 |
1.Padda, S.,Neal, J.W., and Wakelee, H.A. MET inhibitors in combination with other therapies in non-small cell lung cancer. Transl.Lung Cancer Res. 1(4), 238-253 (2012).
|
| 运输条件 | Room temperature in continental US; may vary elsewhere |
| 存放说明 | -20 |
| 纯度 | ≥98% |
| 计算分子量 | 517.6 |
| 分子式 | C26H20FN5O2S2 |
| CAS号 | 875337-44-3 |
| 稳定性 | ≥ 2 years |
声明| 本官网所有报价均为常温或者蓝冰运输价格，如有产品需要干冰运输，需另外加收干冰运输费。 |
